Pylarify
Ended Awarded Last action
- Contract number
- 36C25224F0198
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $124,296
Award facts
- Contract value 100% obligated
- $124,296.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$74,183 | |
| Other Administrative Action | -$252,610 | |
| Original award | $451,090 |
About this award
This federal contract award is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. that specializes in innovative diagnostic imaging agents and targeted oncology therapies.
The contract, valued at $124,296.48, was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) and is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. This master agreement allows various government healthcare providers, including the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH) Clinical Center, to efficiently procure PYLARIFY and other radiopharmaceuticals through streamlined task orders. The contract has a period of performance through August 31, 2024 and is a firm fixed price delivery order, with no set-aside designation.
Quick answers
Who was awarded contract 36C25224F0198?
36C25224F0198 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 15, 2024.
How much is contract 36C25224F0198 worth?
The government has obligated $124,296 on 36C25224F0198.
Is contract 36C25224F0198 an order under another contract?
Yes. 36C25224F0198 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25224F0198 competed?
The extent of competition for 36C25224F0198 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award